Newmark Biosciences Private Limited

Newmark Biosciences Private Limited - pharma in Bareilly, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U51101UP2015PTC072512 Incorporated 05 August 2015 ROC Uttar Pradesh HQ Bareilly, Uttar Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹71.96 Lakh
▼ 13% YoY
Net loss · FY 2024
₹3.23 Lakh
Net margin -4.5%
EBITDA · FY 2024
-₹5,614
EBITDA margin -0.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Newmark Biosciences Private Limited

Data last updated:

Newmark Biosciences Private Limited is a private limited company based in Bareilly, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 August 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51101UP2015PTC072512. Its GSTIN is 09AAECN9996M1ZB (Uttar Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jitin Arora and Nitin Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 44 Ekta Nagar, Bareilly, Uttar Pradesh, India – 243001.

As per the financials filed for FY 2024, the company reported a revenue of ₹71.96 Lakh, a decline of 13% compared to the previous year. For the same year it recorded a net loss of ₹3.23 Lakh (net margin -4.5%) and EBITDA of -₹5,614 (EBITDA margin -0.1%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years and 16% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Newmark Biosciences Private Limited
CIN U51101UP2015PTC072512
Registration Number 072512
Incorporation Date 05 August 2015
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    C – 44 Ekta Nagar, Bareilly, Uttar Pradesh, India – 243001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Newmark Biosciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Newmark Biosciences Private Limited report

Financials, compliance, directors, charges, ownership and filings for Newmark Biosciences Private Limited in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Business Activity of Newmark Biosciences Private Limited

The main business activity of Newmark Biosciences is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Newmark Biosciences Private Limited FY 2025 filings available

Newmark Biosciences Private Limited reported revenue of ₹71.96 Lakh (down 13% YoY) for FY 2024.

Revenue · FY 2024
₹71.96 Lakh ▼ 13%
Net loss · FY 2024
₹3.23 Lakh margin -4.5%
EBITDA · FY 2024
-₹5,614 margin -0.1%

Compounded Annual Growth Rate (CAGR) of Newmark Biosciences Private Limited

Revenue CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 16%
5 years · compounded
▼ 16%
EBITDA CAGR growth
1 year
▲ 99%
3 years · compounded
▼ 26%
5 years · compounded
▼ 15%

Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 13% fall in the latest year. EBITDA rose 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Newmark Biosciences Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹5,614••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹3.23 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Newmark Biosciences Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-0.1%••••••••••••••••
Net Profit Margin-4.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Newmark Biosciences are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Newmark Biosciences Private Limited

Newmark Biosciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Biosciences, Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
MHS Pharmaceuticals Private Limited₹72.2 Lakh (FY 2024)••••••••-27.0%••••Hyderabad, Telangana, India
Gennex Health Care Private Limited₹72.19 Lakh (FY 2023)••••••••••••Hyderabad, Telangana, India
Voluenta Pharmaceuticals Private Limited₹72.03 Lakh (FY 2025)••••••••-22.0%••••New Delhi, Delhi, India
Pan Bioscience Private Limited₹72.01 Lakh (FY 2019)••••••••-51.0%••••Chennai, Tamil Nadu, India
Styris Pharma Private Limited₹71.98 Lakh (FY 2021)••••••••-32.0%••••Telangana, India
Newmark Biosciences Private Limited this company₹71.96 Lakh (FY 2024)••••••••-13.0%••••Bareilly, Uttar Pradesh, India
Midlife Biosciences Private Limited₹71.68 Lakh (FY 2025)••••••••8.0%••••Kanpur, Uttar Pradesh, India
Dorris Pharmaceuticals Private Limited₹71.6 Lakh (FY 2024)••••••••-9.0%••••Delhi, India
PPJ Pharma Private Limited₹71.57 Lakh (FY 2025)••••••••4978.0%••••Thane, Maharashtra, India
Abisai Farma Private Limited₹71.46 Lakh (FY 2024)••••••••76.0%••••Chennai, Tamil Nadu, India
Basappa Memorial Hospital Private Limited₹71.19 Lakh (FY 2022)••••••••1739.0%••••Mysore, Karnataka, India

Peers are the five companies nearest above and the five nearest below Newmark Biosciences by revenue in the Pharma industry (Biosciences, Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Newmark Biosciences Private Limited

Newmark Biosciences Private Limited is audited by VIRENDRA AGARWAL & CO for the financial year 2018.

NameStatusAppointment DateCessation Date
VIRENDRA AGARWAL & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Newmark Biosciences Private Limited

Newmark Biosciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jitin AroraDirector05 Aug 201511 Years 2 MonthsCurrent
Nitin SharmaDirector05 Aug 201511 Years 2 MonthsCurrent

Ownership and Shareholding of Newmark Biosciences Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Newmark Biosciences Private Limited

Newmark Biosciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Newmark Biosciences Private Limited

Employment history and EPFO contributions of people linked to Newmark Biosciences.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Newmark Biosciences Private Limited

Newmark Biosciences Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Mahesh Chandra Sharma ceased to be Director on 20 Jun 2016.

AGM
Newmark Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Newmark Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Ceased
Mahesh Chandra Sharma ceased to be Director.
Appointed
Jitin Arora was appointed as Director.
Appointed
Nitin Sharma was appointed as Director.
Incorporation
05 Aug 2015
Newmark Biosciences Private Limited was registered on 05 Aug 2015 with Roc Uttar Pradesh I & aged 11 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Newmark Biosciences Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Newmark Biosciences Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Newmark Biosciences Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Newmark Biosciences Private Limited

Newmark Biosciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAECN9996M1ZBUttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Newmark Biosciences Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Newmark Biosciences Private Limited

Newmark Biosciences is an active private limited company based in Bareilly, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 August 2015 (11+ years old) and is registered under CIN U51101UP2015PTC072512.

Newmark Biosciences reported revenue of ₹71.96 Lakh for FY 2024 (down 13% YoY).

Newmark Biosciences has 2 current directors:

Newmark Biosciences reported a net loss of ₹3.23 Lakh (net margin -4.5%) and EBITDA of -₹5,614 (EBITDA margin -0.1%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Newmark Biosciences is -16% over three years and -16% over five years. In the latest year (FY 2024) revenue fell 13%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Newmark Biosciences is 09AAECN9996M1ZB, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Newmark Biosciences is U51101UP2015PTC072512. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Newmark Biosciences was incorporated on 05 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

The peers of Newmark Biosciences by revenue are MHS Pharmaceuticals Private Limited, Gennex Health Care Private Limited, Voluenta Pharmaceuticals Private Limited, Pan Bioscience Private Limited, Styris Pharma Private Limited and 5 more, all in the Pharma industry (Biosciences, Pharma Retail and Distribution).

Mahesh Chandra Sharma ceased to be Director on 20 Jun 2016. Jitin Arora was appointed as Director on 05 Aug 2015. Nitin Sharma was appointed as Director on 05 Aug 2015.

The registered office of Newmark Biosciences is at C – 44 Ekta Nagar, Bareilly, Uttar Pradesh, India – 243001.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available